• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

Hawaii Passes Bill To Prepare For Federal Approval of Psychedelics

Microdose NewsDesk by Microdose NewsDesk
April 13, 2023
in Law & Politics
Reading Time: 2 mins read
A A
Hawaii Passes Bill To Prepare For Federal Approval of Psychedelics

Psychedelic legislation is moving through the Aloha state. 

The Hawaii Senate has approved a bill HB1340, a proposed law that would create an advisory board to explore and prepare for regulations around federal approval of “breakthrough therapies” like psychedelics. 

The bill, originally sponsored by Rep. Adrian Tam (D), had already passed through the House and was in the Senate for possible amendments. The bill would require the state Department of Health (DOH) to establish a Breakthrough Therapy Designation Advisory Council. 

As reported by Marijuana Moment, HB 1340 would: 

  • Create an advisory council, tasked with exploring state and federal regulations on certain psychedelics, in addition to reviewing scientific literature related to using them for mental health treatment.
  • The council would need to assess FDA breakthrough therapies within three months of FDA giving the substance that designation.
    Order Quick Lasix

  • Members of the council would need to include the OWR director, state attorney general, law enforcement director, legislative leadership and a physician. Others could be appointed by top lawmakers and the OWR director.
  • The body would need to examine the “requirements, specifications, and guidelines for a health care professional to prescribe and provide various treatments for patients who may benefit.”

 

The bill passed the Senate on Tuesday without much debate and heads back to the House for another, and perhaps final, vote.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

 

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

For more decrim news, check out Decrim Update: Psychedelic Bills Move Forward in Several States

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
A Deeper Look at atai Life Sciences’ Company Update

Atai Starts New Phase 1 Study of PCN-101 (R-Ketamine)

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.